Literature DB >> 33375370

Finely-Tuned Calcium Oscillations in Osteoclast Differentiation and Bone Resorption.

Hiroyuki Okada1,2, Koji Okabe3, Sakae Tanaka1.   

Abstract

Calcium (Ca2+) plays an important role in regulating the differentiation and function of osteoclasts. Calcium oscillations (Ca oscillations) are well-known phenomena in receptor activator of nuclear factor kappa B ligand (RANKL)-induced osteoclastogenesis and bone resorption via calcineurin. Many modifiers are involved in the fine-tuning of Ca oscillations in osteoclasts. In addition to macrophage colony-stimulating factors (M-CSF; CSF-1) and RANKL, costimulatory signaling by immunoreceptor tyrosine-based activation motif-harboring adaptors is important for Ca oscillation generation and osteoclast differentiation. DNAX-activating protein of 12 kD is always necessary for osteoclastogenesis. In contrast, Fc receptor gamma (FcRγ) works as a key controller of osteoclastogenesis especially in inflammatory situation. FcRγ has a cofactor in fine-tuning of Ca oscillations. Some calcium channels and transporters are also necessary for Ca oscillations. Transient receptor potential (TRP) channels are well-known environmental sensors, and TRP vanilloid channels play an important role in osteoclastogenesis. Lysosomes, mitochondria, and endoplasmic reticulum (ER) are typical organelles for intracellular Ca2+ storage. Ryanodine receptor, inositol trisphosphate receptor, and sarco/endoplasmic reticulum Ca2+ ATPase on the ER modulate Ca oscillations. Research on Ca oscillations in osteoclasts has still many problems. Surprisingly, there is no objective definition of Ca oscillations. Causality between Ca oscillations and osteoclast differentiation and/or function remains to be examined.

Entities:  

Keywords:  calcium oscillation; costimulatory signal; immunoreceptor tyrosine-based activation motif (ITAM); osteoclast; receptor activator of nuclear factor kappa B ligand (RANKL); transient receptor potential (TRP) channel

Year:  2020        PMID: 33375370     DOI: 10.3390/ijms22010180

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  5 in total

1.  Biocompatible reduced graphene oxide stimulated BMSCs induce acceleration of bone remodeling and orthodontic tooth movement through promotion on osteoclastogenesis and angiogenesis.

Authors:  Delong Jiao; Jing Wang; Wenting Yu; Ke Zhang; Ning Zhang; Lingyan Cao; Xinquan Jiang; Yuxing Bai
Journal:  Bioact Mater       Date:  2022-02-06

Review 2.  Roles of calcium signaling in cancer metastasis to bone.

Authors:  Tianying Xie; Sitong Chen; Jiang Hao; Pengfei Wu; Xuelian Gu; Haifeng Wei; Zhenxi Li; Jianru Xiao
Journal:  Explor Target Antitumor Ther       Date:  2022-08-31

3.  Inflammatory activation of the FcγR and IFNγR pathways co-influences the differentiation and activity of osteoclasts.

Authors:  Bettina Groetsch; Elisabeth Schachtschabel; Philipp Tripal; Benjamin Schmid; Ana-Suncana Smith; Georg Schett; Aline Bozec
Journal:  Front Immunol       Date:  2022-09-06       Impact factor: 8.786

4.  MCU Inhibitor Ruthenium Red Alleviates the Osteoclastogenesis and Ovariectomized Osteoporosis via Suppressing RANKL-Induced ROS Production and NFATc1 Activation through P38 MAPK Signaling Pathway.

Authors:  Yuxin Wang; Xiang Li; Shengji Zhou; Jiarui Li; Yi Zhu; Quan Wang; Fengchao Zhao
Journal:  Oxid Med Cell Longev       Date:  2022-09-13       Impact factor: 7.310

Review 5.  Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments.

Authors:  Kazuhiro Maeda; Ken Yoshida; Tetsuro Nishizawa; Kazuhiro Otani; Yu Yamashita; Hinako Okabe; Yuka Hadano; Tomohiro Kayama; Daitaro Kurosaka; Mitsuru Saito
Journal:  Int J Mol Sci       Date:  2022-03-06       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.